[PBF] The company's new kidney disease drug Nephoxil approved for marketing in China
NQ Score
0/100
N1 Content Completeness
5
AI Summary (NQ-processed)
PBF Biotechs' Nephoxil 500mg Capsule has received approval from China's NMPA for controlling hyperphosphatemia in adult chronic kidney disease patients on dialysis.